The UK has seen a surge in the number of type 2 diabetes cases, with data analysis from Diabetes UK showing that one in five ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after ...

Some 226,000 people have diabetes in Wales, while another estimated 269,000 people have prediabetes, which, left untreated, ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Greater weight loss was linked to lower discontinuation rates, with a 1% reduction in weight lowering the hazard of ...

New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...